Your browser doesn't support javascript.
loading
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts.
Vasu, Sumithira; He, Shun; Cheney, Carolyn; Gopalakrishnan, Bhavani; Mani, Rajeswaran; Lozanski, Gerard; Mo, Xiaokui; Groh, Veronica; Whitman, Susan P; Konopitzky, Renate; Kössl, Christian; Bucci, Donna; Lucas, David M; Yu, Jianhua; Caligiuri, Michael A; Blum, William; Adam, Paul J; Borges, Eric; Rueter, Bjoern; Heider, Karl-Heinz; Marcucci, Guido; Muthusamy, Natarajan.
Afiliação
  • Vasu S; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, and.
  • He S; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, and.
  • Cheney C; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, and.
  • Gopalakrishnan B; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, and.
  • Mani R; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, and.
  • Lozanski G; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, and.
  • Mo X; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH;
  • Groh V; Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA;
  • Whitman SP; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, and.
  • Konopitzky R; Research Oncology, Boehringer Ingelheim RCV, Vienna, Austria;
  • Kössl C; Research Oncology, Boehringer Ingelheim RCV, Vienna, Austria;
  • Bucci D; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, and.
  • Lucas DM; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, and.
  • Yu J; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, and.
  • Caligiuri MA; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, and.
  • Blum W; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, and.
  • Adam PJ; Research Oncology, Boehringer Ingelheim RCV, Vienna, Austria;
  • Borges E; Research Oncology, Boehringer Ingelheim RCV, Vienna, Austria;
  • Rueter B; Medicine Oncology, Boehringer Ingelheim Pharma GmbH, Biberach/Riss, Germany; and.
  • Heider KH; Research Oncology, Boehringer Ingelheim RCV, Vienna, Austria;
  • Marcucci G; Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope, Duarte, CA.
  • Muthusamy N; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, and.
Blood ; 127(23): 2879-89, 2016 06 09.
Article em En | MEDLINE | ID: mdl-27013443

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Células Matadoras Naturais / Leucemia Mieloide Aguda / Lectina 3 Semelhante a Ig de Ligação ao Ácido Siálico / Anticorpos Monoclonais / Citotoxicidade Celular Dependente de Anticorpos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Células Matadoras Naturais / Leucemia Mieloide Aguda / Lectina 3 Semelhante a Ig de Ligação ao Ácido Siálico / Anticorpos Monoclonais / Citotoxicidade Celular Dependente de Anticorpos Idioma: En Ano de publicação: 2016 Tipo de documento: Article